Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol

Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2003-01, Vol.121 (4), p.1063-1074
Hauptverfasser: Fan, L.-W, Tien, L.-T, Tanaka, S, Ma, T, Chudapongse, N, Sinchaisuk, S, Rockhold, R.W, Ho, I.K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1074
container_issue 4
container_start_page 1063
container_title Neuroscience
container_volume 121
creator Fan, L.-W
Tien, L.-T
Tanaka, S
Ma, T
Chudapongse, N
Sinchaisuk, S
Rockhold, R.W
Ho, I.K
description Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.
doi_str_mv 10.1016/S0306-4522(03)00299-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18952139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452203002999</els_id><sourcerecordid>18952139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</originalsourceid><addsrcrecordid>eNqFkM1O3DAQgC1EBcvSR2jlC4geAv5N1ieEVtBWWqmHtmfLsSddo2yc2gkrXo2H6DPh7K7g2LnMjPTNjz6EPlFyTQktb34STspCSMauCP9CCFOqUEdoRhcVLyopxDGavSGn6CylR5JDCn6CTqmQC6JkOUPdcm26P5Cw7_CwBlxHk6t_L0XoffAOR7DQDyHiFp6gTTg0OJphh2_9sHbRbE2Lmxg2uF8_J29z56CHzkFnAY996HA95gV9vhPac_ShMW2Cj4c8R78f7n8tvxWrH1-_L-9WhRWMDYUEWtayIo5ZSZxiVKqa0KpSilJriVCVaGrlytIYQcEBNMCY4dRYZWQtFZ-jy_3ePoa_I6RBb3yy0LamgzAmTRdKMsonUO5BG0NKERrdR78x8VlToifReidaTxY14XonWk9znw8HxnoD7n3qYDYDFwfApCyliaazPr1zkpWE84m73XPZLjx5iDpZP7lzPrsftAv-P6-8Aki1nDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18952139</pqid></control><display><type>article</type><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</creator><creatorcontrib>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</creatorcontrib><description>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/S0306-4522(03)00299-9</identifier><identifier>PMID: 14580956</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Analgesics ; Animals ; Behavior, Animal - drug effects ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; butorphanol ; Butorphanol - adverse effects ; immunoblotting analysis ; Male ; Medical sciences ; morphine ; Morphine - adverse effects ; Naloxone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics - adverse effects ; Neuropharmacology ; Opioid-Related Disorders - metabolism ; Opioid-Related Disorders - physiopathology ; Pharmacology. Drug treatments ; physical dependence ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, kappa - drug effects ; Receptors, Opioid, kappa - metabolism ; Receptors, Opioid, mu - drug effects ; Receptors, Opioid, mu - metabolism ; Substance Withdrawal Syndrome - metabolism ; Substance Withdrawal Syndrome - physiopathology ; Up-Regulation - drug effects ; Up-Regulation - physiology ; withdrawal ; κ-opioid receptors</subject><ispartof>Neuroscience, 2003-01, Vol.121 (4), p.1063-1074</ispartof><rights>2003 IBRO</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</citedby><cites>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0306-4522(03)00299-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15260336$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14580956$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, L.-W</creatorcontrib><creatorcontrib>Tien, L.-T</creatorcontrib><creatorcontrib>Tanaka, S</creatorcontrib><creatorcontrib>Ma, T</creatorcontrib><creatorcontrib>Chudapongse, N</creatorcontrib><creatorcontrib>Sinchaisuk, S</creatorcontrib><creatorcontrib>Rockhold, R.W</creatorcontrib><creatorcontrib>Ho, I.K</creatorcontrib><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</description><subject>Analgesics</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>butorphanol</subject><subject>Butorphanol - adverse effects</subject><subject>immunoblotting analysis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>morphine</subject><subject>Morphine - adverse effects</subject><subject>Naloxone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics - adverse effects</subject><subject>Neuropharmacology</subject><subject>Opioid-Related Disorders - metabolism</subject><subject>Opioid-Related Disorders - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>physical dependence</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Opioid, kappa - drug effects</subject><subject>Receptors, Opioid, kappa - metabolism</subject><subject>Receptors, Opioid, mu - drug effects</subject><subject>Receptors, Opioid, mu - metabolism</subject><subject>Substance Withdrawal Syndrome - metabolism</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Up-Regulation - drug effects</subject><subject>Up-Regulation - physiology</subject><subject>withdrawal</subject><subject>κ-opioid receptors</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1O3DAQgC1EBcvSR2jlC4geAv5N1ieEVtBWWqmHtmfLsSddo2yc2gkrXo2H6DPh7K7g2LnMjPTNjz6EPlFyTQktb34STspCSMauCP9CCFOqUEdoRhcVLyopxDGavSGn6CylR5JDCn6CTqmQC6JkOUPdcm26P5Cw7_CwBlxHk6t_L0XoffAOR7DQDyHiFp6gTTg0OJphh2_9sHbRbE2Lmxg2uF8_J29z56CHzkFnAY996HA95gV9vhPac_ShMW2Cj4c8R78f7n8tvxWrH1-_L-9WhRWMDYUEWtayIo5ZSZxiVKqa0KpSilJriVCVaGrlytIYQcEBNMCY4dRYZWQtFZ-jy_3ePoa_I6RBb3yy0LamgzAmTRdKMsonUO5BG0NKERrdR78x8VlToifReidaTxY14XonWk9znw8HxnoD7n3qYDYDFwfApCyliaazPr1zkpWE84m73XPZLjx5iDpZP7lzPrsftAv-P6-8Aki1nDA</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Fan, L.-W</creator><creator>Tien, L.-T</creator><creator>Tanaka, S</creator><creator>Ma, T</creator><creator>Chudapongse, N</creator><creator>Sinchaisuk, S</creator><creator>Rockhold, R.W</creator><creator>Ho, I.K</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20030101</creationdate><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><author>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Analgesics</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>butorphanol</topic><topic>Butorphanol - adverse effects</topic><topic>immunoblotting analysis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>morphine</topic><topic>Morphine - adverse effects</topic><topic>Naloxone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics - adverse effects</topic><topic>Neuropharmacology</topic><topic>Opioid-Related Disorders - metabolism</topic><topic>Opioid-Related Disorders - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>physical dependence</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Opioid, kappa - drug effects</topic><topic>Receptors, Opioid, kappa - metabolism</topic><topic>Receptors, Opioid, mu - drug effects</topic><topic>Receptors, Opioid, mu - metabolism</topic><topic>Substance Withdrawal Syndrome - metabolism</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Up-Regulation - drug effects</topic><topic>Up-Regulation - physiology</topic><topic>withdrawal</topic><topic>κ-opioid receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fan, L.-W</creatorcontrib><creatorcontrib>Tien, L.-T</creatorcontrib><creatorcontrib>Tanaka, S</creatorcontrib><creatorcontrib>Ma, T</creatorcontrib><creatorcontrib>Chudapongse, N</creatorcontrib><creatorcontrib>Sinchaisuk, S</creatorcontrib><creatorcontrib>Rockhold, R.W</creatorcontrib><creatorcontrib>Ho, I.K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, L.-W</au><au>Tien, L.-T</au><au>Tanaka, S</au><au>Ma, T</au><au>Chudapongse, N</au><au>Sinchaisuk, S</au><au>Rockhold, R.W</au><au>Ho, I.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>121</volume><issue>4</issue><spage>1063</spage><epage>1074</epage><pages>1063-1074</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>14580956</pmid><doi>10.1016/S0306-4522(03)00299-9</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2003-01, Vol.121 (4), p.1063-1074
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_18952139
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Analgesics
Animals
Behavior, Animal - drug effects
Biological and medical sciences
Brain - drug effects
Brain - metabolism
butorphanol
Butorphanol - adverse effects
immunoblotting analysis
Male
Medical sciences
morphine
Morphine - adverse effects
Naloxone - pharmacology
Narcotic Antagonists - pharmacology
Narcotics - adverse effects
Neuropharmacology
Opioid-Related Disorders - metabolism
Opioid-Related Disorders - physiopathology
Pharmacology. Drug treatments
physical dependence
Rats
Rats, Sprague-Dawley
Receptors, Opioid, kappa - drug effects
Receptors, Opioid, kappa - metabolism
Receptors, Opioid, mu - drug effects
Receptors, Opioid, mu - metabolism
Substance Withdrawal Syndrome - metabolism
Substance Withdrawal Syndrome - physiopathology
Up-Regulation - drug effects
Up-Regulation - physiology
withdrawal
κ-opioid receptors
title Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A10%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20the%20brain%20%CE%BA-opioid%20receptor%20levels%20of%20rats%20in%20withdrawal%20from%20physical%20dependence%20upon%20butorphanol&rft.jtitle=Neuroscience&rft.au=Fan,%20L.-W&rft.date=2003-01-01&rft.volume=121&rft.issue=4&rft.spage=1063&rft.epage=1074&rft.pages=1063-1074&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/S0306-4522(03)00299-9&rft_dat=%3Cproquest_cross%3E18952139%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18952139&rft_id=info:pmid/14580956&rft_els_id=S0306452203002999&rfr_iscdi=true